Search results
Ahmed Aboeata
Author
Author(s):
Amish Raval
Added:
1 year ago
ACC 2025 - Principal results from autologous cell therapy in patients with heart failure with reduced ejection fraction (HFrEF) show favourable safety outcomes, however, the study did not meet its primary efficacy outcome using 6 minute walking rests as 3rd F-S tier.Dr Amish Raval (UW Health University Hospital Interventional Cardiology Clinic, WI, US) joins us onsite at ACC to discuss the…
View more
Josip Katic
Author
Maja Rojko
Author
Metka Zorc
Author
Author(s):
Milind Y Desai
Added:
1 year ago
ACC 2025 - First-in-human results from MyPEAK-1 show Tn-201 treatment in adults with Mybpc3-associated hypertropic cardiomyopathy was feasible and safe.Dr Milind Desai (Cleveland Clinic, Ohio, US) joins us onsite at ACC 2025 to discuss phase Ib/2a results from the first-in-human, non-randomized study investigating the safety and early efficacy of Tn-201, an adeno-associated virus serotype 9 gene…
View more
Agnieszka Kotalczyk
Job title: Research Fellow
Author
Sayan Sen
Job title: Lead, Cardiology
Author
Soha Romeih
Author
Gary E Raskob
Job title: PhD
Author